InsidersTradesSigma
Track the 吉林敖东 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 吉林敖东 has published 2 reports. Market capitalisation: €21.8bn. The latest transaction was filed on 26 July 2024 (Purchase). Among the most active insiders: 郭淑芹. The full history is free.
2
Insider Decl.
n/a
Thresholds
€1m
2 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,354 of 29,064 companies
65.7
score / 100
Value66
Quality65
FCF yld0.7%
Earn yld11%
EV/EBITDA8.9x
ROE8.8%
Gross mgn48%
Net mgn·
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 July 2024
关于 吉林敖东
Jilin Aodong 是一家专注于健康和制药领域的公司，提供各种医药产品。该公司在 XSHE 市场上市。